Ice Miller served as co-counsel in the representation of client Colossal Biosciences, a leading-edge genetic engineering company, in the announcement of its $200 million Series C financing by TWG Global, a diversified holding company with operating businesses and investments in technology/AI, financial services, private lending and sports and media. Colossal will leverage this latest infusion of capital to continue to advance its genetic engineering technologies while pioneering new revolutionary software, wetware and hardware solutions, which have applications beyond de-extinction including species preservation and human healthcare. Since launching in September 2021, Colossal has raised $435M in total funding. This latest round of capital places the company at a $10.2 billion valuation. The Ice Miller team was led by TaeSoo Sean Kim, with support from Dann Bruno, Josh Borean, and Simone Park. Intellectual Property counsel was provided by Fabian Koenigbauer and Andrew Baraniak.

To learn more about this novel and impactful endeavor, please review Colossal’s press release, which goes into great detail regarding its strides in the scientific breakthroughs toward “de-extinction,” or bringing back extinct species like the woolly mammoth, thylacine and the dodo.

As noted in Colossal’s release, “This funding will grow our team, support new technology development, expand our de-extinction species list, while continuing to allow us to carry forth our mission to make extinction a thing of the past.”